Back
ESC Premium Access

The impact of highest doses of ACEi/ARB therapy on mortality of patients suffering from heart failure with reduced ejection fraction: a long-term follow-up, propensity-matched cohort study

Session: Poster Session 2 - Treatment of heart failure
Topic: Pharmacotherapy
Speaker: Doctor B. Muk (Budapest, HU)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Balazs Muk

Gottsegen National Cardiovascular Center, Budapest (Hungary)
2 presentations
0 follower

8 more presentations in this session

Pharmacological treatment of patients with HFrEF: is it really optimized in case of CRT and/or ICD implantation?

Speaker: Professor D. Logeart (Paris, FR)

Access
Abstract
Like
Thumbnail

Evolution of level of evidence c recommendations in european society of cardiology clinical practice guidelines on heart failure

Speaker: Doctor M. Trindade (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Therapy treatment, adherence and persistence in chronic heart failure patients: a populaion study, from 2005 to TO 2012 in Lombardy

Speaker: Doctor S. Scalvini (Lumezzane, IT)

Access
Abstract
Slides
Like
Thumbnail

The myocardial tissue Renin-Angiotensin-System (RAS) of the failing heart

Speaker: Doctor N. Pavo (Vienna, AT)

Access
Abstract
Like
Thumbnail

All cause mortality outcomes of various types of stem cell therapies in patients with dilated cardiomyopathy: an updated meta analysis and systematic review

Speaker: Doctor Y. Illahi (Multan, PK)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 2 - Treatment of heart failure

Speakers: Doctor B. Muk, Professor D. Logeart, Doctor M. Trindade, Doctor S. Scalvini, Doctor N. Pavo...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources